BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364:1746-1760. [PMID: 21542745 DOI: 10.1056/nejmra1011670] [Cited by in Crossref: 338] [Cited by in F6Publishing: 125] [Article Influence: 30.7] [Reference Citation Analysis]
Number Citing Articles
1 Wenzel P. Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosis. Eur Heart J 2022:ehac459. [PMID: 35979817 DOI: 10.1093/eurheartj/ehac459] [Reference Citation Analysis]
2 Li J, Tong D, Song B, Xie F, Zhang G, Hao X, Li W, Chi H, Wang W, Shao Y. Inflammatory cytokines induce neutrophil extracellular traps interaction with activated platelets and endothelial cells exacerbate coagulation in moderate and severe essential hypertension. J Hypertens 2022. [PMID: 35950987 DOI: 10.1097/HJH.0000000000003250] [Reference Citation Analysis]
3 Cui J, Li H, Chen Z, Dong T, He X, Wei Y, Li Z, Duan J, Cao T, Chen Q, Ma D, Zhou Y, Wang B, Shi M, Zhang Q, Xiong L, Qin D. Thrombo-Inflammation and Immunological Response in Ischemic Stroke: Focusing on Platelet-Tregs Interaction. Front Cell Neurosci 2022;16:955385. [DOI: 10.3389/fncel.2022.955385] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao F, Rahman F. DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm. Curr Atheroscler Rep 2022. [PMID: 35386093 DOI: 10.1007/s11883-022-01022-w] [Reference Citation Analysis]
5 Zouheira D, Ngnokam SLW, Kamani SLP, Tchegnitegni BT, Jouda JB, Mba JR, Nchouwet ML, Nfor NG, Nyirimigabo AK, Kowa TK, Agbor GA, Laranjo M. In Vitro Antilipidic and Antithrombotic Activities of Plectranthus glandulosus (Lamiaceae) Leaves Extracts and Fractions. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/4145659] [Reference Citation Analysis]
6 Vandercappellen EJ, Koster A, Savelberg HHCM, Eussen SJPM, Dagnelie PC, Schaper NC, Schram MT, van der Kallen CJH, van Greevenbroek MMJ, Wesselius A, Schalkwijk CG, Kroon AA, Henry RMA, Stehouwer CDA. Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation-relevance for (pre)diabetes: The Maastricht Study. Diabetologia 2022. [PMID: 35119485 DOI: 10.1007/s00125-022-05651-3] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Marquis-gravel G, Robert-halabi M, Bainey KR, Tanguay J, Mehta SR. The Evolution of Antiplatelet Therapy Following Percutaneous Coronary Interventions: a 40-Year Journey. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.02.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Paszek E, Pociask E, Ząbczyk M, Piórkowski A, Butenas S, Legutko J, Undas A. Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.02.009] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ling Y, Wang W, Fu C, Fan Q, Liu J, Tang S. The Relationship between Red Cell Distribution Width and Residual SYNTAX Scores in ST-Segment Elevation Myocardial Infarction Patients after Percutaneous Coronary Intervention. Dis Markers 2021;2021:3281837. [PMID: 34956418 DOI: 10.1155/2021/3281837] [Reference Citation Analysis]
10 Willems LH, Nagy M, Ten Cate H, Spronk HMH, Groh LA, Leentjens J, Janssen NAF, Netea MG, Thijssen DHJ, Hannink G, van Petersen AS, Warlé MC. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res 2022;209:106-14. [PMID: 34922160 DOI: 10.1016/j.thromres.2021.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Mazur P, Kopytek M, Ząbczyk M, Undas A, Natorska J. Towards Personalized Therapy of Aortic Stenosis. J Pers Med 2021;11:1292. [PMID: 34945764 DOI: 10.3390/jpm11121292] [Reference Citation Analysis]
12 Peng J, Liu MM, Liu HH, Guo YL, Wu NQ, Dong Q, Qian J, Dou KF, Zhu CG, Li JJ. Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study. Thromb J 2021;19:90. [PMID: 34809656 DOI: 10.1186/s12959-021-00344-0] [Reference Citation Analysis]
13 Deter HC, Orth-Gomér K, Rauch-Kröhnert U, Albus C, Ladwig KH, Söllner W, de Zwaan M, Grün AS, Ronel J, Hellmich M, Herrmann-Lingen C, Weber C; SPIRR-CAD - Study Group. Depression, anxiety, and vital exhaustion are associated with pro-coagulant markers in depressed patients with coronary artery disease - A cross sectional and prospective secondary analysis of the SPIRR-CAD trial. J Psychosom Res 2021;151:110659. [PMID: 34763203 DOI: 10.1016/j.jpsychores.2021.110659] [Reference Citation Analysis]
14 Ot S, Zafar L, Beg M, Siddiqui OA. Association of Mean Platelet Volume with Risk Factors and Functional Outcome in Acute Ischemic Stroke. J Neurosci Rural Pract 2021;12:764-9. [PMID: 34737513 DOI: 10.1055/s-0041-1735326] [Reference Citation Analysis]
15 Mrozinska S, Wypasek E, Broniatowska E, Undas A. Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study. Sci Rep 2021;11:21003. [PMID: 34702844 DOI: 10.1038/s41598-021-00411-6] [Reference Citation Analysis]
16 Jang GW, Lee JM, Choi SW, Kim J, Lee YS, Kim HO, Chung H, Woo JS, Kim JB, Kim WS, Kim W. Vascular Protective Effects of New Oral Anticoagulants in Patients with Atrial Fibrillation. J Clin Med 2021;10:4332. [PMID: 34640348 DOI: 10.3390/jcm10194332] [Reference Citation Analysis]
17 Pistrosch F, Matschke JB, Schipp D, Schipp B, Henkel E, Weigmann I, Sradnick J, Bornstein SR, Birkenfeld AL, Hanefeld M. Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers. Diabetologia 2021;64:2701-12. [PMID: 34495376 DOI: 10.1007/s00125-021-05562-9] [Reference Citation Analysis]
18 Kyriakopoulos C, Gogali A, Kostikas K, Konstantinidis A. Hypercoagulable State in COPD-A Comprehensive Literature Review. Diagnostics (Basel) 2021;11:1447. [PMID: 34441381 DOI: 10.3390/diagnostics11081447] [Reference Citation Analysis]
19 Kumric M, Borovac JA, Ticinovic Kurir T, Martinovic D, Frka Separovic I, Baric L, Bozic J. Role of Matrix Gla Protein in the Complex Network of Coronary Artery Disease: A Comprehensive Review. Life (Basel) 2021;11:737. [PMID: 34440481 DOI: 10.3390/life11080737] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, Tousoulis D. Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines 2021;9:781. [PMID: 34356845 DOI: 10.3390/biomedicines9070781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ząbczyk M, Natorska J, Undas A. Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes. J Clin Med 2021;10:2999. [PMID: 34279484 DOI: 10.3390/jcm10132999] [Reference Citation Analysis]
22 Zhang X, Song L, Li L, Zhu B, Huo L, Hu Z, Wang X, Wang J, Gao M, Zhang J, Hua Z. Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy. Signal Transduct Target Ther 2021;6:235. [PMID: 34131110 DOI: 10.1038/s41392-021-00626-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Siegal DM, Anand SS. Considerations for use of direct oral anticoagulants in arterial disease. Res Pract Thromb Haemost 2021;5. [PMID: 34095731 DOI: 10.1002/rth2.12502] [Reference Citation Analysis]
24 Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 2021;18:666-82. [PMID: 33958774 DOI: 10.1038/s41569-021-00552-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 58] [Article Influence: 5.0] [Reference Citation Analysis]
25 Babur Ö, Melrose AR, Cunliffe JM, Klimek J, Pang J, Sepp AI, Zilberman-Rudenko J, Tassi Yunga S, Zheng T, Parra-Izquierdo I, Minnier J, McCarty OJT, Demir E, Reddy AP, Wilmarth PA, David LL, Aslan JE. Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs. Blood 2020;136:2346-58. [PMID: 32640021 DOI: 10.1182/blood.2020005496] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
26 Xu T, Chen S, Yang F, Wang Y, Zhang K, Fu G, Zhang W. The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study. Acta Diabetol 2021;58:301-7. [PMID: 33113028 DOI: 10.1007/s00592-020-01608-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Pizzolo F, Castagna A, Olivieri O, Girelli D, Friso S, Stefanoni F, Udali S, Munerotto V, Baroni M, Cetera V, Luciani GB, Faggian G, Bernardi F, Martinelli N. Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease. J Am Heart Assoc 2021;10:e018243. [PMID: 33624506 DOI: 10.1161/JAHA.120.018243] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 von Känel R, Hamer M, Wentzel A, Malan L. Circulating neurotrophins and hemostatic risk factors of atherothrombotic cardiovascular disease at baseline and during sympathetic challenge: the SABPA study. Sci Rep 2021;11:2297. [PMID: 33504912 DOI: 10.1038/s41598-021-81946-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ngo ATP, Parra-Izquierdo I, Aslan JE, McCarty OJT. Rho GTPase regulation of reactive oxygen species generation and signalling in platelet function and disease. Small GTPases 2021;12:440-57. [PMID: 33459160 DOI: 10.1080/21541248.2021.1878001] [Reference Citation Analysis]
30 Aslan JE. Platelet Proteomes, Pathways, and Phenotypes as Informants of Vascular Wellness and Disease. Arterioscler Thromb Vasc Biol 2021;41:999-1011. [PMID: 33441027 DOI: 10.1161/ATVBAHA.120.314647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
31 Ewees MGE, Abdel-Bakky MS, Bayoumi AMA, Abo-Saif AA, Altowayan WM, Alharbi KS, Messiha BAS. Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway. J Adv Res 2021;31:127-36. [PMID: 34194837 DOI: 10.1016/j.jare.2020.12.014] [Reference Citation Analysis]
32 Rohmann JL, Longstreth WT Jr, Cushman M, Fitzpatrick AL, Heckbert SR, Rice K, Rosendaal FR, Sitlani CM, Psaty BM, Siegerink B. Coagulation factor VIII, white matter hyperintensities and cognitive function: Results from the Cardiovascular Health Study. PLoS One 2020;15:e0242062. [PMID: 33196677 DOI: 10.1371/journal.pone.0242062] [Reference Citation Analysis]
33 Bourassa KA, Postolache TT, Dagdag A, Fuchs D, Okusaga OO. Plasma soluble P-selectin correlates with triglycerides and nitrite in overweight/obese patients with schizophrenia. Pteridines 2020;31:61-7. [PMID: 32982068 DOI: 10.1515/pteridines-2020-0012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Hounkpe BW, Benatti RO, Carvalho BS, De Paula EV. Identification of common and divergent gene expression signatures in patients with venous and arterial thrombosis using data from public repositories. PLoS One 2020;15:e0235501. [PMID: 32780732 DOI: 10.1371/journal.pone.0235501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Golia N, Krishan K, Kashyap JR. Assessment of Obesity by Using Various Anthropometric Measurements among Patients with Coronary Heart Disease Residing in North India. Cureus 2020;12:e7948. [PMID: 32509474 DOI: 10.7759/cureus.7948] [Reference Citation Analysis]
36 Xu JH, Lu SJ, Wu P, Kong LC, Ning C, Li HY. Molecular mechanism whereby paraoxonase-2 regulates coagulation activation through endothelial tissue factor in rat haemorrhagic shock model. Int Wound J 2020;17:735-41. [PMID: 32090497 DOI: 10.1111/iwj.13329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV. CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmgenomics Pers Med 2020;13:29-37. [PMID: 32158254 DOI: 10.2147/PGPM.S234910] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Capodanno D, Bhatt DL, Eikelboom JW, Fox KAA, Geisler T, Michael Gibson C, Gonzalez-Juanatey JR, James S, Lopes RD, Mehran R, Montalescot G, Patel M, Steg PG, Storey RF, Vranckx P, Weitz JI, Welsh R, Zeymer U, Angiolillo DJ. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease. Nat Rev Cardiol 2020;17:242-57. [PMID: 31953535 DOI: 10.1038/s41569-019-0314-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 18.5] [Reference Citation Analysis]
39 Olivieri O, Turcato G, Moruzzi S, Castagna A, Girelli D, Pizzolo F, Friso S, Sandri M, Bassi A, Martinelli N. Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII. J Am Heart Assoc 2019;8:e010973. [PMID: 30646800 DOI: 10.1161/JAHA.118.010973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
40 Coppini R, Santini L, Palandri C, Sartiani L, Cerbai E, Raimondi L. Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial Fibrillation. Front Pharmacol 2019;10:1420. [PMID: 31956307 DOI: 10.3389/fphar.2019.01420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
41 Eggebrecht L, Prochaska JH, Schulz A, Arnold N, Jünger C, Göbel S, Laubert-Reh D, Binder H, Beutel ME, Pfeiffer N, Blankenberg S, Lackner KJ, Spronk HM, Ten Cate H, Münzel T, Wild PS. Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study. J Am Heart Assoc 2018;7:e008650. [PMID: 30371151 DOI: 10.1161/JAHA.118.008650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
42 Jaminon A, Reesink K, Kroon A, Schurgers L. The Role of Vascular Smooth Muscle Cells in Arterial Remodeling: Focus on Calcification-Related Processes. Int J Mol Sci 2019;20:E5694. [PMID: 31739395 DOI: 10.3390/ijms20225694] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 18.0] [Reference Citation Analysis]
43 Raghavan S, Singh NK, Gali S, Mani AM, Rao GN. Protein Kinase Cθ Via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6Chi Cells Contributes to Atherosclerosis. Circulation 2018;138:2395-412. [PMID: 29991487 DOI: 10.1161/CIRCULATIONAHA.118.034083] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
44 Franchi F, Rollini F, Kairouz V, Rivas Rios J, Rivas A, Agarwal M, Briceno M, Wali M, Nawaz A, Silva G, Shaikh Z, Maaliki N, Been L, Piraino J, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Jennings LK, Bass TA, Angiolillo DJ. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. JACC Basic Transl Sci 2019;4:763-75. [PMID: 31998847 DOI: 10.1016/j.jacbts.2019.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
45 Zhang A, Hou Y, Sun C, Pu Y, Sun Y, Zhang Y, Shen Y, Zhou Q. Baicalin Protects against Thrombin-Induced Cell Injury in Human Umbilical Vein Endothelial Cells. Biomed Res Int 2019;2019:2187306. [PMID: 31467874 DOI: 10.1155/2019/2187306] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Pham PT, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M. Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice. Sci Rep 2019;9:11206. [PMID: 31371788 DOI: 10.1038/s41598-019-47474-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
47 Tsai SF, Wu MJ, Wen MC, Chen CH. Serologic and Histologic Predictors of Long-Term Renal Outcome in Biopsy-Confirmed IgA Nephropathy (Haas Classification): An Observational Study. J Clin Med 2019;8:E848. [PMID: 31207869 DOI: 10.3390/jcm8060848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
48 Wang J, Li X, Pu J, Jin S, Jia L, Li X, Liu F, Yang Y. Mean platelet volume and coronary plaque vulnerability: an optical coherence tomography study in patients with non-ST-elevation acute coronary syndrome. BMC Cardiovasc Disord 2019;19:128. [PMID: 31142268 DOI: 10.1186/s12872-019-1115-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sui W, Li H, Yang Y, Jing X, Xue F, Cheng J, Dong M, Zhang M, Pan H, Chen Y, Zhang Y, Zhou Q, Shi W, Wang X, Zhang H, Zhang C, Zhang Y, Cao Y. Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis. Proc Natl Acad Sci U S A 2019;116:10937-42. [PMID: 31085638 DOI: 10.1073/pnas.1901655116] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
50 Li B, Liu Y, Hu T, Zhang Y, Zhang C, Li T, Wang C, Dong Z, Novakovic VA, Hu T, Shi J. Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol 2019;145:1695-707. [PMID: 31020419 DOI: 10.1007/s00432-019-02922-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
51 Tsai SF, Wu MJ, Chen CH. Low serum C3 level, high neutrophil-lymphocyte-ratio, and high platelet-lymphocyte-ratio all predicted poor long-term renal survivals in biopsy-confirmed idiopathic membranous nephropathy. Sci Rep 2019;9:6209. [PMID: 30996263 DOI: 10.1038/s41598-019-42689-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
52 Posthuma JJ, Posma JJN, van Oerle R, Leenders P, van Gorp RH, Jaminon AMG, Mackman N, Heitmeier S, Schurgers LJ, Ten Cate H, Spronk HMH. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice. Sci Rep 2019;9:3909. [PMID: 30846818 DOI: 10.1038/s41598-019-40602-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
53 Mokou M, Klein J, Makridakis M, Bitsika V, Bascands JL, Saulnier-Blache JS, Mullen W, Sacherer M, Zoidakis J, Pieske B, Mischak H, Roubelakis MG, Schanstra JP, Vlahou A. Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease. EBioMedicine 2019;41:91-104. [PMID: 30826357 DOI: 10.1016/j.ebiom.2019.02.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
54 Mohamed AB, Elnady HM, Alhewaig HK, Moslem Hefny H, Khodery A. The mean platelet volume and plateletcrit as predictors of short-term outcome of acute ischemic stroke. Egypt J Neurol Psychiatr Neurosurg 2019;55:4. [PMID: 30686914 DOI: 10.1186/s41983-018-0035-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
55 Eggebrecht L, Prochaska JH, Tröbs SO, Schwuchow-Thonke S, Göbel S, Diestelmeier S, Schulz A, Arnold N, Panova-Noeva M, Koeck T, Rapp S, Gori T, Lackner KJ, Ten Cate H, Münzel T, Wild PS. Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism. Clin Res Cardiol 2019;108:787-96. [PMID: 30604046 DOI: 10.1007/s00392-018-1408-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
56 Kikuchi S, Tsukahara K, Sakamaki K, Morita Y, Takamura T, Fukui K, Endo T, Shimizu M, Sawada R, Sugano T, Himeno H, Kobayashi S, Arakawa K, Mochida Y, Tsunematsu T, Shigemasa T, Okuda J, Ishikawa T, Kimura K, Tamura K. Comparison of anti-inflammatory effects of rivaroxaban vs. dabigatran in patients with non-valvular atrial fibrillation (RIVAL-AF study): multicenter randomized study. Heart Vessels 2019;34:1002-13. [PMID: 30599063 DOI: 10.1007/s00380-018-01324-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
57 Gutowska K, Formanowicz D, Formanowicz P. Selected Aspects of Tobacco-Induced Prothrombotic State, Inflammation and Oxidative Stress: Modeled and Analyzed Using Petri Nets. Interdiscip Sci 2019;11:373-86. [PMID: 30584644 DOI: 10.1007/s12539-018-0310-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Lee J, Nakanishi R, Li D, Shaikh K, Shekar C, Osawa K, Nezarat N, Jayawardena E, Blanco M, Chen M, Sieckert M, Nelson E, Billingsley D, Hamal S, Budoff MJ. Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis. Am Heart J 2018;206:127-30. [PMID: 30227941 DOI: 10.1016/j.ahj.2018.08.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
59 Baaten CCFMJ, Meacham S, de Witt SM, Feijge MAH, Adams DJ, Akkerman JN, Cosemans JMEM, Grassi L, Jupe S, Kostadima M, Mattheij NJA, Prins MH, Ramirez-Solis R, Soehnlein O, Swieringa F, Weber C, White JK, Ouwehand WH, Heemskerk JWM. A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding. Blood 2018;132:e35-46. [PMID: 30275110 DOI: 10.1182/blood-2018-02-831982] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
60 Cimmino G, Cirillo P. Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis. Cardiovasc Diagn Ther 2018;8:581-93. [PMID: 30498683 DOI: 10.21037/cdt.2018.10.14] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
61 Saleh M, Ambrose JA. Understanding myocardial infarction. F1000Res 2018;7:F1000 Faculty Rev-1378. [PMID: 30228871 DOI: 10.12688/f1000research.15096.1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 7.8] [Reference Citation Analysis]
62 Mahmoud SSE, Ismail NA, Farag YM, Hashem RH, Ibrahim MH, Salah MM, Tous AN. Intima media thickness as an early predictor of atherosclerosis in Egyptian children with familial Mediterranean fever. Arch Med Sci Atheroscler Dis 2018;3:e106-11. [PMID: 30775599 DOI: 10.5114/amsad.2018.77545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
63 Cıcek E, Demırel B, Cıcek IE, Kıraç AS, Eren I. Increased Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Male Heroin Addicts: A Prospective Controlled Study. Clin Psychopharmacol Neurosci 2018;16:190-6. [PMID: 29739133 DOI: 10.9758/cpn.2018.16.2.190] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
64 Raghavan S, Singh NK, Mani AM, Rao GN. Protease-activated receptor 1 inhibits cholesterol efflux and promotes atherogenesis via cullin 3-mediated degradation of the ABCA1 transporter. J Biol Chem 2018;293:10574-89. [PMID: 29777060 DOI: 10.1074/jbc.RA118.003491] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
65 Yuan L, Chen C, Li Z, Zhu G, Bao J, Zhao Z, Lu Q, Jing Z. Antiplatelet and anticoagulant for prevention of reocclusion in patients with atrial fibrillation undergoing endovascular treatment for low extremity ischemia. J Thorac Dis 2018;10:1857-63. [PMID: 29707340 DOI: 10.21037/jtd.2018.02.63] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Morishima Y, Honda Y. A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice. J Thromb Thrombolysis 2018;46:95-101. [PMID: 29704172 DOI: 10.1007/s11239-018-1673-7] [Reference Citation Analysis]
67 Dziuba OS; Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv. Blood coagulation and aortic wall integrity in rats with obesity-induced insulin resistance. Ukr Biochem J 2018;90:14-23. [DOI: 10.15407/ubj90.02.014] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
68 Olie RH, van der Meijden PEJ, Ten Cate H. The coagulation system in atherothrombosis: Implications for new therapeutic strategies. Res Pract Thromb Haemost 2018;2:188-98. [PMID: 30046721 DOI: 10.1002/rth2.12080] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
69 Ramanathan R, Sand NPR, Sidelmann JJ, Nørgaard BL, Gram JB. Sex difference in clot lysability and association to coronary artery calcification. Biol Sex Differ 2018;9:9. [PMID: 29439739 DOI: 10.1186/s13293-018-0168-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
70 Spronk HMH, Padro T, Siland JE, Prochaska JH, Winters J, van der Wal AC, Posthuma JJ, Lowe G, d'Alessandro E, Wenzel P, Coenen DM, Reitsma PH, Ruf W, van Gorp RH, Koenen RR, Vajen T, Alshaikh NA, Wolberg AS, Macrae FL, Asquith N, Heemskerk J, Heinzmann A, Moorlag M, Mackman N, van der Meijden P, Meijers JCM, Heestermans M, Renné T, Dólleman S, Chayouâ W, Ariëns RAS, Baaten CC, Nagy M, Kuliopulos A, Posma JJ, Harrison P, Vries MJ, Crijns HJGM, Dudink EAMP, Buller HR, Henskens YMC, Själander A, Zwaveling S, Erküner O, Eikelboom JW, Gulpen A, Peeters FECM, Douxfils J, Olie RH, Baglin T, Leader A, Schotten U, Scaf B, van Beusekom HMM, Mosnier LO, van der Vorm L, Declerck P, Visser M, Dippel DWJ, Strijbis VJ, Pertiwi K, Ten Cate-Hoek AJ, Ten Cate H. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis. Thromb Haemost 2018;118:229-50. [PMID: 29378352 DOI: 10.1160/TH17-07-0492] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
71 Doddapattar P, Dhanesha N, Chorawala MR, Tinsman C, Jain M, Nayak MK, Staber JM, Chauhan AK. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice. Arterioscler Thromb Vasc Biol 2018;38:520-8. [PMID: 29348121 DOI: 10.1161/ATVBAHA.117.309918] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
72 Konstantinides S, Münzel T. Apixaban. Hamostaseologie 2017;32:203-11. [DOI: 10.5482/hamo-12-05-0010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Liaw FY, Huang CF, Chen WL, Wu LW, Peng TC, Chang YW, Kao TW. Higher Platelet-to-Lymphocyte Ratio Increased the Risk of Sarcopenia in the Community-Dwelling Older Adults. Sci Rep 2017;7:16609. [PMID: 29192175 DOI: 10.1038/s41598-017-16924-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
74 Zhou F, Zhou L, Guo T, Wang N, Hao H, Zhou Y, Yu D. Plasma proteomics reveals coagulation, inflammation, and metabolic shifts in H-type hypertension patients with and without acute ischemic stroke. Oncotarget 2017;8:100384-95. [PMID: 29245986 DOI: 10.18632/oncotarget.22233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
75 Zheng CF, Liu WY, Zeng FF, Zheng MH, Shi HY, Zhou Y, Pan JY. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury. Crit Care 2017;21:238. [PMID: 28882170 DOI: 10.1186/s13054-017-1821-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
76 Nazir S, Gadi I, Al-Dabet MM, Elwakiel A, Kohli S, Ghosh S, Manoharan J, Ranjan S, Bock F, Braun-Dullaeus RC, Esmon CT, Huber TB, Camerer E, Dockendorff C, Griffin JH, Isermann B, Shahzad K. Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition. Blood 2017;130:2664-77. [PMID: 28882883 DOI: 10.1182/blood-2017-05-782102] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
77 Ahmad AS, Mendes M, Hernandez D, Doré S. Efficacy of Laropiprant in Minimizing Brain Injury Following Experimental Intracerebral Hemorrhage. Sci Rep 2017;7:9489. [PMID: 28842638 DOI: 10.1038/s41598-017-09994-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
78 Lewis JR, Lim WH, Wong G, Abbs S, Zhu K, Lim EM, Thompson PL, Prince RL. Association Between High-Sensitivity Cardiac Troponin I and Cardiac Events in Elderly Women. J Am Heart Assoc 2017;6:e004174. [PMID: 28757482 DOI: 10.1161/JAHA.116.004174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
79 Zhang H, Wang J, Li L, Chai N, Chen Y, Wu F, Zhang W, Wang L, Shi S, Zhang L, Bian S, Xu C, Tian Y, Zhao Y. Spermine and spermidine reversed age-related cardiac deterioration in rats. Oncotarget 2017;8:64793-808. [PMID: 29029392 DOI: 10.18632/oncotarget.18334] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
80 Olivier CB, Weik P, Meyer M, Weber S, Diehl P, Bode C, Moser M, Zhou Q. Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors. J Thromb Thrombolysis 2016;42:161-6. [PMID: 26961375 DOI: 10.1007/s11239-016-1350-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
81 Martínez-Sánchez SM, Minguela A, Prieto-Merino D, Zafrilla-Rentero MP, Abellán-Alemán J, Montoro-García S. The Effect of Regular Intake of Dry-Cured Ham Rich in Bioactive Peptides on Inflammation, Platelet and Monocyte Activation Markers in Humans. Nutrients 2017;9:E321. [PMID: 28333093 DOI: 10.3390/nu9040321] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
82 Wu MD, Atkinson TM, Lindner JR. Platelets and von Willebrand factor in atherogenesis. Blood 2017;129:1415-9. [PMID: 28174163 DOI: 10.1182/blood-2016-07-692673] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
83 Amraotkar AR, Song DD, Otero D, Trainor PJ, Ismail I, Kothari V, Singh A, Moore JB 4th, Rai SN, DeFilippis AP. Platelet Count and Mean Platelet Volume at the Time of and After Acute Myocardial Infarction. Clin Appl Thromb Hemost 2017;23:1052-9. [PMID: 28294633 DOI: 10.1177/1076029616683804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
84 Luo M, Peng D. The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism. Lipids Health Dis 2016;15:184. [PMID: 27770802 DOI: 10.1186/s12944-016-0352-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
85 Yazar FM, Urfalioglu A, Bakacak M, Boran ÖF, Bülbüloğlu E. Efficacy of the Evaluation of Inflammatory Markers for the Reduction of Negative Appendectomy Rates. Indian J Surg 2018;80:61-7. [PMID: 29581687 DOI: 10.1007/s12262-016-1558-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
86 Mozzini C, Garbin U, Fratta Pasini AM, Cominacini L. An exploratory look at NETosis in atherosclerosis. Intern Emerg Med 2017;12:13-22. [PMID: 27655025 DOI: 10.1007/s11739-016-1543-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
87 Bester J, Pretorius E. Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Sci Rep 2016;6:32188. [PMID: 27561337 DOI: 10.1038/srep32188] [Cited by in Crossref: 121] [Cited by in F6Publishing: 158] [Article Influence: 20.2] [Reference Citation Analysis]
88 Kim JB, Joung HJ, Lee JM, Woo JS, Kim WS, Kim KS, Lee KH, Kim W. Evaluation of the vascular protective effects of new oral anticoagulants in high-risk patients with atrial fibrillation (PREFER-AF): study protocol for a randomized controlled trial. Trials 2016;17:422. [PMID: 27558002 DOI: 10.1186/s13063-016-1541-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
89 Valente-Acosta B, Baños-González MA, Peña-Duque MA, Martínez-Ríos MA, Quintanar-Trejo L, Aptilon-Duque G, Flores-García M, Cruz-Robles D, Cardoso-Saldaña G, de la Peña-Díaz A. Association between Stable Coronary Artery Disease and In Vivo Thrombin Generation. Cardiol Res Pract 2016;2016:5149825. [PMID: 27597926 DOI: 10.1155/2016/5149825] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
90 Ten Cate H, Hemker HC. Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate? J Am Heart Assoc 2016;5:e003553. [PMID: 27503850 DOI: 10.1161/JAHA.116.003553] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
91 Wang NC, Matthews KA, Barinas-Mitchell EJ, Chang CC, El Khoudary SR. Inflammatory/Hemostatic Biomarkers and Coronary Artery Calcium Progression in Women at Midlife (from the Study of Women's Health Across the Nation, Heart Study). Am J Cardiol 2016;118:311-8. [PMID: 27289291 DOI: 10.1016/j.amjcard.2016.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
92 Loeffen R, van Oerle R, Leers MP, Kragten JA, Crijns H, Spronk HM, Ten Cate H. Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events. PLoS One 2016;11:e0158355. [PMID: 27419389 DOI: 10.1371/journal.pone.0158355] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
93 Wang Y, Qiu J, Luo S, Xie X, Zheng Y, Zhang K, Ye Z, Liu W, Gregersen H, Wang G. High shear stress induces atherosclerotic vulnerable plaque formation through angiogenesis. Regen Biomater 2016;3:257-67. [PMID: 27482467 DOI: 10.1093/rb/rbw021] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
94 Sedgwick MJ, Thompson M, Garnham J, Thackray AE, Barrett LA, Powis M, Stensel DJ. Acute high-intensity interval rowing increases thrombin generation in healthy men. Eur J Appl Physiol 2016;116:1139-48. [PMID: 27072545 DOI: 10.1007/s00421-016-3370-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
95 Horn P, Erkilet G, Veulemans V, Kröpil P, Schurgers L, Zeus T, Heiss C, Kelm M, Westenfeld R. Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis. PLoS One 2016;11:e0151499. [PMID: 27010400 DOI: 10.1371/journal.pone.0151499] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
96 Tsujimoto M, Kuroyanagi G, Matsushima-Nishiwaki R, Kito Y, Enomoto Y, Iida H, Ogura S, Otsuka T, Tokuda H, Kozawa O, Iwama T. Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase. PLoS One 2016;11:e0149077. [PMID: 26867010 DOI: 10.1371/journal.pone.0149077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
97 Shnerb Ganor R, Harats D, Schiby G, Gailani D, Levkovitz H, Avivi C, Tamarin I, Shaish A, Salomon O. Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice. Arterioscler Thromb Vasc Biol 2016;36:475-81. [PMID: 26800563 DOI: 10.1161/ATVBAHA.115.306954] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
98 Palekar RU, Jallouk AP, Myerson JW, Pan H, Wickline SA. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis. Arterioscler Thromb Vasc Biol 2016;36:446-55. [PMID: 26769047 DOI: 10.1161/ATVBAHA.115.306697] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
99 Cho HM, Kang DR, Kim HC, Oh SM, Kim BK, Suh I. Association between Fibrinogen and Carotid Atherosclerosis According to Smoking Status in a Korean Male Population. Yonsei Med J 2015;56:921-7. [PMID: 26069112 DOI: 10.3349/ymj.2015.56.4.921] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
100 van Gorp RH, Schurgers LJ. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs). Nutrients 2015;7:9538-57. [PMID: 26593943 DOI: 10.3390/nu7115479] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
101 Stote KS, Tracy RP, Taylor PR, Baer DJ. The effect of moderate alcohol consumption on biomarkers of inflammation and hemostatic factors in postmenopausal women. Eur J Clin Nutr 2016;70:470-4. [PMID: 26554758 DOI: 10.1038/ejcn.2015.182] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
102 Yau JW, Teoh H, Verma S. Endothelial cell control of thrombosis. BMC Cardiovasc Disord. 2015;15:130. [PMID: 26481314 DOI: 10.1186/s12872-015-0124-z] [Cited by in Crossref: 249] [Cited by in F6Publishing: 218] [Article Influence: 35.6] [Reference Citation Analysis]
103 Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev 2015;:CD011054. [PMID: 26310586 DOI: 10.1002/14651858.CD011054.pub2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
104 Maino A, Rosendaal FR, Algra A, Peyvandi F, Siegerink B. Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review. PLoS One 2015;10:e0133523. [PMID: 26252207 DOI: 10.1371/journal.pone.0133523] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
105 Kondoh C, Shitara K, Nomura M, Takahari D, Ura T, Tachibana H, Tomita N, Kodaira T, Muro K. Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study. BMC Palliat Care 2015;14:37. [PMID: 26238344 DOI: 10.1186/s12904-015-0034-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
106 DuBroff R, de Lorgeril M. Cholesterol confusion and statin controversy. World J Cardiol 2015; 7(7): 404-409 [PMID: 26225201 DOI: 10.4330/wjc.v7.i7.404] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
107 Loeffen R, Godschalk TC, van Oerle R, Spronk HM, Hackeng CM, ten Berg JM, ten Cate H. The hypercoagulable profile of patients with stent thrombosis. Heart 2015;101:1126-32. [PMID: 25999588 DOI: 10.1136/heartjnl-2014-306685] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
108 Qin H, Liu P, Lin S. Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE(-/-) Mice Induced by Hyperlipaemia. Evid Based Complement Alternat Med 2015;2015:385154. [PMID: 26074989 DOI: 10.1155/2015/385154] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
109 Andrikopoulos P, Kieswich J, Harwood SM, Baba A, Matsuda T, Barbeau O, Jones K, Eccles SA, Yaqoob MM. Endothelial Angiogenesis and Barrier Function in Response to Thrombin Require Ca2+ Influx through the Na+/Ca2+ Exchanger. J Biol Chem 2015;290:18412-28. [PMID: 25979335 DOI: 10.1074/jbc.M114.628156] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
110 Ben Shimon M, Lenz M, Ikenberg B, Becker D, Shavit Stein E, Chapman J, Tanne D, Pick CG, Blatt I, Neufeld M, Vlachos A, Maggio N. Thrombin regulation of synaptic transmission and plasticity: implications for health and disease. Front Cell Neurosci 2015;9:151. [PMID: 25954157 DOI: 10.3389/fncel.2015.00151] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
111 Peng YF, Cao L, Zeng YH, Zhang ZX, Chen D, Zhang Q, Zhu YS. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis. Open Med (Wars) 2015;10:249-53. [PMID: 28352702 DOI: 10.1515/med-2015-0037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
112 von Känel R. ACUTE MENTAL STRESS AND HEMOSTASIS: WHEN PHYSIOLOGY BECOMES VASCULAR HARM. Thromb Res 2015;135:S52-5. [PMID: 25861135 DOI: 10.1016/S0049-3848(15)50444-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 10] [Article Influence: 6.1] [Reference Citation Analysis]
113 Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care 2014;2:67. [PMID: 25705424 DOI: 10.1186/s40560-014-0065-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 8.5] [Reference Citation Analysis]
114 Scribano Mde L, Baez Mdel C, Florencia B, Tarán MD, Franco S, Balceda AG, Moya M. Effects of Atorvastatin on Oxidative Stress Biomarkers and Mitochondrial Morphofunctionality in Hyperfibrinogenemia-Induced Atherogenesis. Adv Med 2014;2014:947258. [PMID: 26556431 DOI: 10.1155/2014/947258] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
115 Burgmaier M, Schutters K, Willems B, van der Vorst EP, Kusters D, Chatrou M, Norling L, Biessen EA, Cleutjens J, Perretti M, Schurgers LJ, Reutelingsperger CP. AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(-/-) mice. J Cell Mol Med 2014;18:2117-24. [PMID: 25214012 DOI: 10.1111/jcmm.12374] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
116 von Hundelshausen P, Schmitt MM. Platelets and their chemokines in atherosclerosis-clinical applications. Front Physiol 2014;5:294. [PMID: 25152735 DOI: 10.3389/fphys.2014.00294] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
117 Koltsova EK, Sundd P, Zarpellon A, Ouyang H, Mikulski Z, Zampolli A, Ruggeri ZM, Ley K. Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis. Thromb Haemost. 2014;112:1252-1263. [PMID: 25104056 DOI: 10.1160/th14-02-0130] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
118 Carnevale R, Loffredo L, Nocella C, Bartimoccia S, Bucci T, De Falco E, Peruzzi M, Chimenti I, Biondi-Zoccai G, Pignatelli P, Violi F, Frati G. Epicatechin and catechin modulate endothelial activation induced by platelets of patients with peripheral artery disease. Oxid Med Cell Longev 2014;2014:691015. [PMID: 25180068 DOI: 10.1155/2014/691015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
119 Shivu GN, Ossei-Gerning N. Rivaroxaban in patients with a recent acute coronary syndrome event: integration of trial findings into clinical practice. Vasc Health Risk Manag 2014;10:291-302. [PMID: 24868164 DOI: 10.2147/VHRM.S59420] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Akbas EM, Hamur H, Demirtas L, Bakirci EM, Ozcicek A, Ozcicek F, Kuyrukluyildiz U, Turkmen K. Predictors of epicardial adipose tissue in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 2014;6:55. [PMID: 24822086 DOI: 10.1186/1758-5996-6-55] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
121 de Andrade Moura L, Marqui de Almeida AC, Domingos TF, Ortiz-Ramirez F, Cavalcanti DN, Teixeira VL, Fuly AL. Antiplatelet and anticoagulant effects of diterpenes isolated from the marine alga, Dictyota menstrualis. Mar Drugs 2014;12:2471-84. [PMID: 24796305 DOI: 10.3390/md12052471] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
122 Spronk HM, Borissoff JI, ten Cate H. New insights into modulation of thrombin formation. Curr Atheroscler Rep 2013;15:363. [PMID: 24026641 DOI: 10.1007/s11883-013-0363-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
123 Chaterji S, Lam CH, Ho DS, Proske DC, Baker AB. Syndecan-1 regulates vascular smooth muscle cell phenotype. PLoS One 2014;9:e89824. [PMID: 24587062 DOI: 10.1371/journal.pone.0089824] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
124 Zhang Y, Yang R, Burwinkel B, Breitling LP, Holleczek B, Schöttker B, Brenner H. F2RL3 methylation in blood DNA is a strong predictor of mortality. Int J Epidemiol 2014;43:1215-25. [PMID: 24510982 DOI: 10.1093/ije/dyu006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
125 Lang IM. Thrombosis - Besieged but Poorly Understood. Front Cardiovasc Med 2014;1:4. [PMID: 26664856 DOI: 10.3389/fcvm.2014.00004] [Reference Citation Analysis]
126 Olivieri O, Martinelli N, Baroni M, Branchini A, Girelli D, Friso S, Pizzolo F, Bernardi F. Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele. J Am Heart Assoc 2013;2:e000440. [PMID: 24242684 DOI: 10.1161/JAHA.113.000440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
127 Savchenko AS, Borissoff JI, Martinod K, De Meyer SF, Gallant M, Erpenbeck L, Brill A, Wang Y, Wagner DD. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood 2014;123:141-8. [PMID: 24200682 DOI: 10.1182/blood-2013-07-514992] [Cited by in Crossref: 142] [Cited by in F6Publishing: 144] [Article Influence: 15.8] [Reference Citation Analysis]
128 Hadoke PW, Kipari T, Seckl JR, Chapman KE. Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation. Curr Atheroscler Rep 2013;15:320. [PMID: 23512604 DOI: 10.1007/s11883-013-0320-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
129 Danckwardt S, Hentze MW, Kulozik AE. Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond. J Mol Med (Berl). 2013;91:1257-1271. [PMID: 23955016 DOI: 10.1007/s00109-013-1074-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
130 Wallace EL, Smyth SS. Targeting platelet thrombin receptor signaling to prevent thrombosis. Pharmaceuticals (Basel) 2013;6:915-28. [PMID: 24276376 DOI: 10.3390/ph6080915] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
131 Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Ten Cate H, Hofstra L. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol. 2013;33:2032-2040. [PMID: 23818485 DOI: 10.1161/atvbaha.113.301627] [Cited by in Crossref: 228] [Cited by in F6Publishing: 134] [Article Influence: 25.3] [Reference Citation Analysis]
132 Smid M, Dielis AW, Spronk HM, Rumley A, van Oerle R, Woodward M, ten Cate H, Lowe G. Thrombin generation in the Glasgow Myocardial Infarction Study. PLoS One 2013;8:e66977. [PMID: 23826181 DOI: 10.1371/journal.pone.0066977] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
133 Mulrooney DA, Ness KK, Huang S, Solovey A, Hebbel RP, Neaton JD, Clohisy DR, Kelly AS, Neglia JP. Pilot study of vascular health in survivors of osteosarcoma. Pediatr Blood Cancer 2013;60:1703-8. [PMID: 23720361 DOI: 10.1002/pbc.24610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
134 Wong CK, White HD. Rivaroxaban for the treatment of acute coronary syndromes. Expert Opin Pharmacother 2013;14:917-27. [PMID: 23544968 DOI: 10.1517/14656566.2013.780029] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
135 Owens AP 3rd, Mackman N. Role of tissue factor in atherothrombosis. Curr Atheroscler Rep 2012;14:394-401. [PMID: 22886473 DOI: 10.1007/s11883-012-0269-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
136 van Bussel BC, Ferreira I, van de Waarenburg MP, van Greevenbroek MM, van der Kallen CJ, Henry RM, Feskens EJ, Stehouwer CD, Schalkwijk CG. Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform. PLoS One 2013;8:e58576. [PMID: 23472208 DOI: 10.1371/journal.pone.0058576] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
137 Kusters DH, Tegtmeier J, Schurgers LJ, Reutelingsperger CP. Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice. Mol Imaging Biol 2012;14:523-33. [PMID: 22983911 DOI: 10.1007/s11307-012-0586-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
138 van Ryn J, Goss A, Hauel N, Wienen W, Priepke H, Nar H, Clemens A. The discovery of dabigatran etexilate. Front Pharmacol 2013;4:12. [PMID: 23408233 DOI: 10.3389/fphar.2013.00012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
139 Borissoff JI, Otten JJ, Heeneman S, Leenders P, van Oerle R, Soehnlein O, Loubele ST, Hamulyák K, Hackeng TM, Daemen MJ, Degen JL, Weiler H, Esmon CT, van Ryn J, Biessen EA, Spronk HM, ten Cate H. Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner. PLoS One 2013;8:e55784. [PMID: 23409043 DOI: 10.1371/journal.pone.0055784] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 9.4] [Reference Citation Analysis]
140 Willeit P, Thompson A, Aspelund T, Rumley A, Eiriksdottir G, Lowe G, Gudnason V, Di Angelantonio E. Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses. PLoS One 2013;8:e55175. [PMID: 23408959 DOI: 10.1371/journal.pone.0055175] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 7.7] [Reference Citation Analysis]
141 Kling MA, Trojanowski JQ, Wolk DA, Lee VM, Arnold SE. Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement 2013;9:76-92. [PMID: 23183137 DOI: 10.1016/j.jalz.2012.02.007] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 8.5] [Reference Citation Analysis]
142 Schurgers LJ, Joosen IA, Laufer EM, Chatrou ML, Herfs M, Winkens MH, Westenfeld R, Veulemans V, Krueger T, Shanahan CM, Jahnen-Dechent W, Biessen E, Narula J, Vermeer C, Hofstra L, Reutelingsperger CP. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One 2012;7:e43229. [PMID: 22952653 DOI: 10.1371/journal.pone.0043229] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 9.9] [Reference Citation Analysis]
143 Lui MM, Sau-Man M. OSA and atherosclerosis. J Thorac Dis 2012;4:164-72. [PMID: 22833822 DOI: 10.3978/j.issn.2072-1439.2012.01.06] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
144 Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2012;32:1777-1783. [PMID: 22652600 DOI: 10.1161/atvbaha.111.242859] [Cited by in Crossref: 320] [Cited by in F6Publishing: 168] [Article Influence: 32.0] [Reference Citation Analysis]
145 Macchia A, Laffaye N, Comignani PD, Cornejo Pucci E, Igarzabal C, Scazziota AS, Herrera L, Mariani JA, Bragagnolo JC, Catalano H, Tognoni G, Nicolucci A. Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial. PLoS One 2012;7:e32894. [PMID: 22470429 DOI: 10.1371/journal.pone.0032894] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
146 Kreutz RP, Breall JA, Kreutz Y, Owens J, Lu D, Bolad I, von der Lohe E, Sinha A, Flockhart DA. Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response. Thromb Res 2012;130:198-202. [PMID: 22459907 DOI: 10.1016/j.thromres.2012.02.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
147 Arévalo-Lorido JC, Carretero-Gómez J, Villar-Vaca P. Mean platelet volume predicting carotid atherosclerosis in atherothrombotic ischemic stroke. Ir J Med Sci 2012;181:179-83. [PMID: 21928050 DOI: 10.1007/s11845-011-0755-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
148 Yan P, Xia C, Duan C, Li S, Mei Z. Biological characteristics of foam cell formation in smooth muscle cells derived from bone marrow stem cells. Int J Biol Sci 2011;7:937-46. [PMID: 21850203 DOI: 10.7150/ijbs.7.937] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
149 Chen IC, Yu CC, Wu YH, Chao TH. Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty. Acta Cardiol Sin 2016;32:532-41. [PMID: 27713601 DOI: 10.6515/acs20150731d] [Cited by in F6Publishing: 6] [Reference Citation Analysis]